's Information

Jung-Min Ahn , MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  1. The Fate of Deferred Lesions; Insight From the IRIS-FFR Registry
  2. Rule of 5-6-7-8 for Bifurcation PCI: It Is Time to Change in 2024
  3. Left Main AMI with Cardiogenic Shock, How to Rescue?
  4. Choosing Wisely: FFR vs. Anatomy Dilemma in LM PCI and Introduction to FATE-MAIN Trial
  5. Precision in Stent Sizing: Insights from Imaging-Guided LM PCI
  6. TAVR for Bicuspid AV: What’s Different?
  7. Synergetic Approach for Discordant Lesions Between FFR and Hyperemia Free Indexes
  8. ASSURE-DES Trial
  9. 10-Year Extended Follow-up of BEST Trial
  10. Defining Lesion Severity (by Angiography, Physiology & IVUS)
  11. Not to Treat
  12. Optimal MSA for LM Crush Technique: New Criteria Any Difference in Any 2 Stent Technique?
  13. TAVR Techniques in Bicuspid Anatomy – Valve Selection, Sizing, and Positioning
  14. How to Optimize 1st Valve Choice Matter for Future
  15. How Can We Treat Patients with Concomitant Coronary Artery Disease?
  16. Low Penetration of FFR (1A Class) in Real Practice; Why and How to Overcome?
  17. Case 4. CTO
  18. CTO Revascularization 2022: Guidelines and Concept Change
  19. Physiologic Approach For Non-LM Bifurcation Disease
  20. Unmet Need for FFR in LM PCI
  21. Minimalist TAVI : Achieving Great TAVI Efficiency and Optimal Patient Outcome
  22. 타비 시술을 위한 CT 평가
  23. TAVR for Bicuspid Valve: Practical Tips and Tricks for Optimal Sizing and Positioning
  24. FFR is a Routine Cath Lab Procedure
  25. FFR, It\'s Standard
  26. The Basics of Coronary Physiology Measurement: FFR, iFR and other NHPRs
  27. Updated Imaging/Physiology-Guided PCI Tuning 2021
  28. Under Pressure: Optimal Post-Dilation Strategy
  29. Difficult Wiring, Tips and Tricks
  30. TAVR for Bicuspid AS: Optimal Sizing & Valve Selection
  31. Imaging-guided PSP for Optimizing PCI
  32. How to Treat Tandem Lesion Under Physiology-Guidance
  33. Guide Extension Catheters: Strong Support from Mother-Child Relationship
  34. Post TAVR Coronary Access with Evolut System
  35. Self-Expandable Evolut R & PRO Valve
  36. TAVR for Bicuspid AV: Tips and Tricks
  37. Bifurcation PCI: Contemporary Practical Approach
  38. The Role of Debulking Atherectomy for Calcific In-stent Restenosis
  39. Prognosis of Discordant Lesion Between FFR and Hyperemia Free Indexes
  40. [Case-based Debate: Intracoronary Imaging Modalities for PCI Guidance] IVUS Is Better!
  41. Clinically Relevant PeriProcedural MI: Practical and Clinical Trial Aspect
  42. Case 1: Unexpanded ISR - Challenging and Optimal Treatment
  43. How Do I Implement?: FFR and Various Non-hyperemic Diastolic Index
  44. Current Status of Balloon-Expandable TAVR in Korea
  45. OAC in TAVR: FAILED GALILEO - NOAC Don\'t Work or Other Options?
  46. TAVR for Bicuspid AV: Tips and Tricks
  47. Synergetic Approach for Discordant Lesions Between FFR and Hyperemia Free Indexes
  48. Guide Extension Catheters: A Strong Support from a Parent-Child Relationship
  49. Expert Case Review: Complex PCI for Severe Calcified Coronary Disease
  50. Expert Case Review: Complex Bifurcation PCI
  51. Impact of Renal Function on Stroke or Systemic Embolism Following TAVR
  52. TAVR for Bicuspid Valve: Clinical Outcome and Technical Considerations
  53. TAVR: Bicuspid, Severe Calcium, and Low Lying Left Main
  54. TAVR in Bicuspid Aortic Stenosis with Severe Calcification: Case Reviews and Tips-and-Tricks
  55. How About Integrated Use of Resting Pd/Pa and FFR?
  56. Distal Left Main Bifurcation PCI: Concept Is More Important.
  57. [Case #2: Transcatheter Aortic Valve Implantation in a Patient with Type B Aortic Dissection] Part 2. How Would I Treat?
  58. FFR as the Gold Standard Index!
  59. Five-Year Outcomes of Routine FFR Use in Clinical Practice: Data from ASAN PCI Registry
  60. The Benefit of Complete Revascularization in Complex Coronary Artery Disease
  61. Asian Pacific TAVR Registry
  62. [Taped Case] TAVR with Evolut R
  63. Bicuspid AS: Future Perspectives of TAVR
  64. Integrated Use of FFR and IVUS for LM PCI
  65. Bicuspid TAVR Registry and TRANSIT Trial: TAVI Experience in AMC
  66. Bicuspid and Valve-in-Valve; How Different?
  67. Clinical Outcome of DEFER
  68. Left Main and MVD PCI: Imaging and Functional Guidance
  69. Utility of Intravascular Imaging for Resolving Issues During PCI
  70. Long Lesion and Tandem Lesion
  71. Bicuspid TAVR Registry
  72. AP TAVR Registry
  73. Current Status of TAVR: High/Intermediate and Lower Risk
  74. Clinical Impact of Routine FFR Measurement
  75. Tandem
  76. Prognostic Value of FFR: Insight from IRIS-FFR Registry
  77. Practical Aspect of IMR in AMI and Stable Angina
  78. Elderly Population
  79. LM PCI 2016: Integrated Approach Using IVUS, FFR and New Imaging Modality
  80. [Review in 2015] Physiology
  81. Tandem Lesion Evaluation
  82. Integrated Use of IVUS and FFR in Real Practice
  83. Readmission After PCI or CABG
  84. Left Main
  85. Final Answer RESTORE
  86. Comparative Outcomes of Various DES from IRIS-MAIN Registry and PRECOMBAT Series
  87. Case Presentation 4: Medically Stabilized Type A Aortic Dissection After TAVI
  88. Randomzed Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: Five-Year Outcomes of the PRECOMBAT Study
  89. Preliminary Data from IRIS FFR Registry
  90. Complex Lesions, Left Main, Bifurcations, Tandem, and More
  91. Left Main PCI
  92. Understanding About Visual-Functional Mismatching
  93. TAVI for Bicuspid Valve Stenosis
  94. FFR-guided PCI in Routine Practice: Learn from AMC Experiences
  95. Is There a Generation Gap of DES: Results of PRECOMBAT Study Series
  96. Clinical Implementation of FFR
  97. Case-based Review: Incidence and Treatment of LM ISR
  98. LM & Tandem Lesion
  99. VH IVUS: Native Plaque and Neointima
  100. Clinical Evidence of Neoatherosclerosis: ISR and Late Stent Thrombosis
  101. LM PCI
  102. IRIS-ELEMENT Data Review
  103. Cross and Perfect: 2013 Update
  104. Anatomical - Functional Stenosis: How Much Discordant?
  105. Case Presentation: Functional Angioplasty
  106. Impact of Functional Angioplasty on Clinical Outcomes of PCI
  107. Novice's Trial of Complex LM PCI
  108. New-generation DES for Long Lesions: From a Large-scale Cohort Regis
  109. FFR Utilization in LM PCI
  110. Promus Element Clinical Program in Asan Medical Center
  111. FFR-guided PCI in Tandem Lesion
  112. Two Cases with Coronary Thromboembolism
  113. Does the Timing of IABP Matter?
Conference Slides
Category